BJL
ALT icon

Brighton Jones LLC’s Altimmune ALT Stock Holding History

Brighton Jones LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3K Buy
+12,596
New +$37.6K ﹤0.01% 1377

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Brighton Jones LLC's ALT Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Altimmune (ALT) in Q2 2026: 12,596 shares worth $38.3K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings.

92 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Brighton Jones LLC held 12,596 shares of Altimmune worth $38.3K as of Q2 2026.
  • Altimmune was a new Brighton Jones LLC position in Q2 2026.
  • Altimmune made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1377 holding.
  • 92 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.